Clinical Trials Browser

OTHER × Imlunestrant × Breast × Clear all

NCT07410559 2026-02-18

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07191717 2025-11-10

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Phase 2 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8